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Microchannel network hydrogel induced ischemic
blood perfusion connection
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Angiogenesis induction into damaged sites has long been an unresolved issue. Local treat-
ment with pro-angiogenic molecules has been the most common approach. However, this
approach has critical side effects including inflammatory coupling, tumorous vascular acti-
vation, and off-target circulation. Here, the concept that a structure can guide desirable
biological function is applied to physically engineer three-dimensional channel networks in
implant sites, without any therapeutic treatment. Microchannel networks are generated in a
gelatin hydrogel to overcome the diffusion limit of nutrients and oxygen three-dimensionally.
Hydrogel implantation in mouse and porcine models of hindlimb ischemia rescues severely
damaged tissues by the ingrowth of neighboring host vessels with microchannel perfusion.
This effect is guided by microchannel size-specific regenerative macrophage polarization with
the consequent functional recovery of endothelial cells. Multiple-site implantation reveals
hypoxia and neighboring vessels as major causative factors of the beneficial function. This
technique may contribute to the development of therapeutics for hypoxia/inflammatory-
related diseases.
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B lood vessel growth into damaged sites or implanted scaf-folds is a pre-requisite process for tissue regeneration1,2.Local treatment with pro-angiogenic molecules such as
vascular endothelial growth factor (VEGF) has been considered
the most promising approach3–5. The molecule is injected to
target sites, released from implants, or delivered via systemic
circulation6–10. However, critical limitations to this approach
include unexpected side effects influenced by off-target sites and
biomolecular treatment. Blood or interstitial flow, as the primary
route for molecules to reach target sites, often guides their delivery
into systemic circulation11. VEGF induces angiogenesis as well as
inflammation, and over-induction of angiogenesis may lead to
tumorous progression12. Although a promising strategy was
reported to address this issue by enabling sustained and low-dose
delivery of VEGF with fibrin biomaterials13, the chronic issues in
pro-angiogenic molecular treatment remain unsolved, and urgently
require an advance in the concept of most current approaches.
As an unexplored solution, vascular networks can be physically
engineered in damaged sites following the concept that structure
guides biological function. Surface patterning, porous scaffold
design, and 3D bioprinting have been widely studied in the past
decade to control cell functions14–18. To become functional, vas-
culatures require the following unique structures: (i) a three-
dimensionally closed network to enable loss-free perfusion from
inlet to outlet points, (ii) branched connections to cover the max-
imum surface area with minimum flow resistance, (iii) high vessel
packing to overcome the 200 µm diffusion limit of oxygen and
nutrients in an omnidirectional manner, and (iv) extracellular
matrix scaffolding to facilitate molecular diffusion to intravascular
spaces and to support in-and-out microvessel growth. Blood flows
preferably through a vascular network that is equipped with the
aforementioned structures. These facts indicate that setting a func-
tional vascular structure inside an implant may induce blood per-
fusion from the host tissue to the implant. Indeed, a previous study
reported that angiogenesis occurred most in ~40 µm pore diameters
with an interconnected inner structure in implantable scaffolds14,15.
The pathophysiological environment also affects angiogenic
processes19,20. The neighboring blood vessels can grow into
damaged sites (angiogenesis) whereas stem cells or monocytes can
differentiate to endothelial progenitor cells (EPCs) even in the
absence of blood vessels (vasculogenesis)21,22. These processes can
be induced by local pathogenic events such as hypoxia and
inflammation23–25. Under hypoxic conditions, the body operates
homeostatic functions to overcome this status, resulting in the
induction of angiogenesis. Monocytes can undergo activation or
phenotype changes to macrophages, osteoclasts, or EPCs in
response to specific pathophysiological signals26. Among these
physiological monocyte functions, EPC differentiation and macro-
phage polarization to pro-inflammatory M1 or pro-angiogenic M2
play regulatory roles in angiogenesis versus vasculogenesis27–29.
Because both EPC and M2 polarization induce the formation of a
vascular network26,27,30, pre-setting the functional vascular structure
may conversely promote these pro-angiogenic monocyte functions.
This study examines the induction of blood perfusion to
damaged sites by implanting a hydrogel containing microchannel
networks to obtain functional vascular structures. The promising
therapeutic effect of hydrogel is demonstrated in mouse and
porcine models of hindlimb ischemia. Its functional vascular
structure with microchannel size results in promoted pro-
angiogenic M2 polarization of macrophages and consequent
functional endothelial cell (EC) recovery.
Results
Channel network hydrogel fabrication. 3D channel network
hydrogels were produced through the following process: (i) poly
(N-isopropylacrylamide) (PNIPAM) was solution-spun to produce
fibers (Fig. 1a and Supplementary Fig. 1). PNIPAM was chosen
owing to its biocompatibility and thermo-responsibility (lower
critical solution temperature (LCST)= 32 °C). (ii) PNIPAM fibers
were embedded in a polydimethylsiloxane (PDMS) mold, then an
enzyme-crosslinkable gelatin solution was poured onto them, fol-
lowed by gelation cross-linking. (iii) The temperature-dependent
water-solubility of PNIPAM enabled the fibers to dissolve by
washing with water perfusion when the temperature was lowered
below 32 °C, representing a non-toxic, organic solvent-free process.
In this way, void channel networks were generated post fiber dis-
solving and perfusion washing (Supplementary Figs. 1 and 2). In
our previous study, the washing process enabled complete removal
of PNIPAM fibers throughout the channel gel when analyzed by
digital imaging and high-performance liquid chromatography
(HPLC)31.
To determine the effect of channel size, micro- and macro-
diameters were produced by controlling PNIPAM fiber diameter.
The resultant channel structure and interconnectivity were
analyzed post FluoSpheres (45 nm, red) perfusion, followed by
confocal imaging because only the interconnected channels
allowed for perfusion staining (Fig. 1b and Supplementary Fig. 3).
The average diameters of micro- and macrochannels were
16.37 ± 7.76 and 150.46 ± 57.02 µm (mean ± SEM), respectively.
The microvasculature-like diffusion and perfusion characteristics
of the channel network were demonstrated (Supplementary
Fig. 4). As a result, fluorescein isothiocyanate (FITC)-labeled
dextran (40 kDa, green) diffused efficiently from the microchan-
nels into the gelatin matrix in the hydrogel, whereas microbeads
(45 nm FluoSpheres, red) perfused well through the microchan-
nels. As the lead-off trial to vascularize damaged tissue using only
the channel network structure of hydrogel, the standard mouse
model of hindlimb ischemia32 was modified to result in several
ischemic damages and consequent limb amputation (Supplemen-
tary Fig. 5a). The two (up and down) points of femoral vessels
were ligated to minimize the spontaneous rescue effect of
collateral formation. Then, right after surgery, a test hydrogel
was implanted in the center of the severe ischemic region between
the two ligation points. In the rescue process developed in this
study, the proximal and distal host vessels grew into the hydrogel,
and were followed by perfusion connection with the micro-
channel network (Supplementary Fig. 5b). This process enabled
blood perfusion from the proximal host vessels (inlet) to
the microchannels, and then to the distal vessels (outlet), as in
the closed circulation system of the body, thereby rescuing the
ischemic limb tissue damage. The following results prove the
developed rescue mechanism.
In the mouse model of severe hindlimb ischemia (Supplemen-
tary Fig. 5a), blood perfusion degrees (Fig. 1c, d) in the hindlimb
with the resulting limb salvage (Fig. 1e) were examined by laser
Doppler perfusion imaging (LDPI) with quantitative analysis at
days 0, 7, and 14 post-implantation of the test hydrogels. Severe
ischemia modeling was successfully induced in the ligated left
hindlimb of each group with a 5–10% blood perfusion ratio to
that of the normal right limb at day 0 (Fig. 1c, d). Overall,
implantation of the microchannel gel enhanced the perfusion
ratio by up to 50% at days 7 and 14, while the normal right limb
maintained a 100% perfusion ratio until day 14. In contrast, the
control (saline and without (w/o) channel) and macrochannel
groups showed progressive limb loss due to the lack of sufficient
perfusion (<30% perfusion ratio) from days 7 to 14. As a result
(Fig. 1e), there was no limb loss with significant limb rescue in the
microchannel group, whereas the other groups showed losses of
the toe, foot, or limb with the lack of limb rescue.
Next, histological examination with hematoxylin and eosin
(H&E) and Masson’s trichrome staining, along with TUNEL
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assay, were conducted using tissue samples from the distal site of
the implant at day 14 post-implantation (Fig. 1f, g). The macro-
and w/o channel groups showed invasion of massive inflamma-
tory cells with formation of severe fibrotic tissues, whereas the
microchannel group showed significant restoration of muscle
tissue to the level of a normal limb, with a normal-like population
of inflammatory cells (Fig. 1f). These results were supported by
the pattern of cell death, in which a significantly smaller number
of TUNEL+ cells were present in the microchannel group
compared to those in the other groups (Fig. 1g). Moreover, the
gene expression of CD31 and αSMA in the microchannel group
was higher than those of the other test groups, indicating a
Process of engineering a channel network hydrogel
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causative role of the microchannel in promoting functional vessel
ingrowth (Fig. 1h).
Vessel ingrowth with perfusion connection. The primary
mechanism through which the severely damaged limb is rescued by
the microchannel hydrogel was investigated. First, the perfusion
connection between the host vessels and the microchannel network
was examined by micro-computed tomography (microCT) and
perfusion-based confocal imaging with quantitative analysis at day
14 post-implantation (Fig. 2a–d) in the mouse model of severe
hindlimb ischemia. In the microCT images with gradual increases in
the magnification (from the top to bottom rows), the microchannel
group showed clear microvessel invasion from the host femoral
artery into the hydrogel in contrast to the other test groups (Fig. 2a).
As a zoom-in support, FluoSphere (red) perfusion-based confocal
images showed clear host vessel ingrowth and perfusion connection
with the microchannel network of the implanted hydrogel, whereas
the red perfusion signal was absent in the other test groups, indi-
cating the lack of the vessel ingrowth (Fig. 2b). Structural char-
acterization of the formed vasculature (Fig. 2c) with quantitative
analysis (Fig. 2d–g) also supported these results. As indicators of the
functional vascular structure, the total branching length, number of
branches and junctions, and fractional area in the microchannel
hydrogel group were significantly higher than those in the other test
groups, reaching a level similar to that of the normal limb. The
branching parameters were measured, as they were essential indi-
cators of blood vessel functionality. As blood vessel branching
increases, the covered surface area increased, thereby enhancing the
delivery efficiency of oxygen and nutrient to every corner of the
tissues33,34. This branched structure also reduces flow resistance by
mimicking the parallel connection of electric circuits35,36.
Macrophage infiltration and polarization. The binary roles of
monocytes in regulating host responses have been widely
studied29,37. In particular, their polarization to destructive M1
and regenerative M2 phenotypes in response to hydrogel channel
size was examined at day 14 post-implantation. Inflammatory
cells infiltrated the microchannel hydrogel implants significantly
more than the other test groups. This was indicated by the gene
expression of representative T cell (CD3) and monocyte/macro-
phage markers (CD68), in addition to CD31 in the implanted
hydrogels after removing the surrounding tissues (Fig. 3a).
Because it is not possible to track inflammatory cell homing into
the implanted sites in real time, RAW264.7 mouse monocytes
were labeled with Vivotrack-680 and injected into mice via the
tail vein at day 3 post-implantation surgery. This was followed by
imaging via in vivo imaging system (IVIS) at 24 h post cell
injection (Fig. 3b). The population of RAW264.7 mouse mono-
cytes homing into the implanted hydrogels and surrounding
tissues was significantly larger in the macrochannel group
compared to the microchannel and saline groups. As shown by
H&E histology and CD68 immunostaining of tissues harvested
around the implants, more macrophages were observed in the
channel hydrogel groups than in the normal and saline groups
(Fig. 3c). The CD68+ populations (Fig. 3a) in the hydrogels only
(as opposed to the homing populations of RAW264.7 mouse
monocytes (Fig. 3b) in the hydrogels and surrounding tissues)
indicated a positive effect of microchannel size on CD68+ cell
infiltration into the implanted hydrogels without surrounding
tissues.
In this situation, destructive M1 and pro-angiogenic M2 polariza-
tion were determined by immunostaining of iNOS (M1) and CD206
(M2) in the implant sites at day 14 post-implantation (Fig. 3d and
Supplementary Fig. 6). M2 polarization of macrophages was more
dominant in the microchannel group than in the macrochannel
group, contrary to the M1 polarization pattern, indicating an M2
polarization mediator in the microchannel hydrogel rescue mechan-
ism. We also examined the channel size-dependent monocyte
polarization in vitro. RAW264.7 cells were M1-stimulated with
lipopolysaccharide (LPS) in macro- and microchannel network
hydrogels. When the activated macrophages were cultured inside
the channel groups for 4 days under media perfusion, the adhered,
spindle cell shapes were dominant in the macrochannels in contrast to
the circular, monocyte-like morphologies in the microchannels,
indicating attenuation of M1 macrophage polarization by micro-
channels (Supplementary Fig. 7). This result was supported by the
quantitative real-time polymerase chain reaction (qRT-PCR) data
(Fig. 3e), in which the gene expression of M2 markers (IL10, Arg-1,
CD163, and CD206) was significantly higher in the microchannel
group than in the macrochannel group as opposed to the expression
pattern of M1 markers (IL-1β, IL-6, TNF-α, CD80, and NOS2).
Compared to the w/o channel group, the two channel groups
increased the in vitro M2 polarization of macrophages, as evidenced
by increased EC migration and tubulogenesis under treatment of the
conditioned media from culture of RAW264.7 cells with LPS
stimulation (Fig. 3f, g). In particular, the degree of tubulogenic
branching in the microchannel group was significantly higher than
that of the rest groups, confirming the pro-angiogenic effect of
microchannel size (Fig. 3f).
Endothelial cell infiltration and ingrowth. As pro-angiogenic
M2 polarization of macrophages with CD31+ cell infiltration was
dominant in the microchannel network hydrogel (Fig. 3), the
consequent behavior of ECs was examined (Fig. 4). The gene
expression for EC markers (KDR and vWF) and a vascular
smooth muscle cell marker (αSMA) was significantly higher in
the microchannel group than in the macrochannel group
(Fig. 4a). EPC infiltration into the micro- and macrochannel
groups was confirmed by the gene (Fig. 4a) and protein (Fig. 4f)
expression of the EPC marker (CD34 and CD133). The
gene expression of a skeletal muscle marker (MyoG) was higher
Fig. 1 Implantation of microchannel network hydrogel in mouse ischemic hindlimb tissue. a Schematic illustration of the procedure to produce poly(N-
isopropylacrylamide) (PNIPAM) fibers, then channel networks, in a hydrogel within a PDMS mold. b Confocal visualization of micro- or macrochannel
networks in hydrogels with their channel diameter distribution. Channels were perfused with FluoSpheres (45 nm, red). Scale bar= 100 μm. c Laser
Doppler perfusion imaging (LDPI) of supine position in a mouse model of hindlimb ischemia with d quantification of the corresponding blood perfusion
ratio, compared to that of normal hindlimb at days 0, 7, and 14 post-implantation (N= 5). Statistical significances are determined using one-way ANOVA
with Tukey post-hoc pairwise comparisons; *p < 0.05 versus saline; #p < 0.05 versus without (w/o) channel; and $p < 0.05 versus macrochannel group.
e Fraction ratio of limb salvage in ischemic hindlimb at day 14 post surgery. f General histology (H&E: top) and fibrotic tissue staining (Masson’s trichrome:
bottom) of distal hindlimb tissue site from the implant. Scale bar= 100 μm. g Cell apoptosis in hindlimb tissue at the distal site from the implant by
terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling (TUNEL) assay with quantitative analysis (N= 5). Scale bars= 100 μm; **p < 0.01 and
***p < 0.005 between lined groups. h Gene expression of CD31 and alpha smooth muscle actin (αSMA) at the distal tissue site from the implant by qRT-
PCR (N= 3). f–h Dots represent each animal. Data presented are mean ± SEM. Statistical significances are determined using one-way ANOVA with Tukey
post-hoc pairwise comparisons; *p < 0.05 between lined groups. Source data are provided as a Source Data file.
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in the macrochannel group than in the microchannel
group, indicating an invasion of skeletal muscle with increased
channel size.
These results were supported by the increases in blood cell
appearance (Fig. 4b, h) and blood spreading (digital images in
Fig. 4h and Supplementary Fig. 6) of the microchannel group
compared those of the macrochannel group in the mouse and
porcine models of hindlimb ischemia. Indeed, markedly more
functional ECs (Lectin+) infiltrated the microchannel than the
macrochannel, as analyzed by immunostaining (Fig. 4c) with
quantitative profiling of Lectin+ cell population and channel
diameter (Fig. 4d). Microchannel-guided vessel ingrowth was
confirmed by marker expression of ECs (CD31) and EPCs (CD34
and CD133) by immunostaining (Fig. 4e–f). In addition, when
GFP-HUVECs were cultured within the channel network
hydrogels under media perfusion, in vitro microchannel
endothelialization was more efficient than in the macrochannels,
as presented by EC lining, tight junction, and capillary-like
sprouting (Fig. 4g and Supplementary Fig. 8 and Movie 1).
Together, the overall interpretation of the results (Figs. 3 and 4)
suggests a causative role of M2 macrophage polarization in
promoting EC infiltration and ingrowth as a mechanism guiding
host vessel ingrowth and perfusion connection with microchannel
networks.
Macro-channel
Channel network hydrogel
Channel network hydrogel
Channel network
hydrogel
Normal
Quantification area Epi-fluorescence
×108
1.4
1.2
1.0
0.8
0.6
0.4
0.2
Saline
Hydrogel +
surrounding tissue
Macro-
channel
Micro-
channel
Channel network hydrogel
Channel network hydrogel
Macro-channel
Im
m
un
os
ta
in
in
g
M
1
M
2
Im
m
un
os
ta
in
in
g
Co
-lo
ca
liz
at
io
n
(iN
OS
/F4
/80
)
Co
-lo
ca
liz
at
io
n
(C
D2
06
/F4
/80
)
Micro-channel
iN
O
S+
, C
D2
06
+ 
ce
lls
[%
 of
 m
ac
rop
ha
ge
 (F
4/8
0+
)]
In vivo
In vitro
In vitro
2.5
Ischemia
modeling
D0 D3 D4
RAW264.7
injection
Raw264.7 seeding
into hyrogel LPS
D2 D4D0
Br
an
ch
es
 (n
um
be
r/m
m2
)
Ce
ll m
ig
ra
tio
n 
(%
, c
ov
ere
d a
rea
)
50 60
40
20
0
0 8 16
Time (h)
24
p < 0.5 vs. w/o channel group
40
30
20
10
0
Treatment
Endothelial cell
Tubulogenesis
Migration
Media
harvest
R
AW
26
4.
7 
ce
ll h
om
in
g 
po
pu
la
tio
n
in
 h
yd
ro
ge
l +
 s
ur
ro
un
di
ng
 ti
ss
ue
(re
lat
ive
 flu
ore
sc
en
ce
 in
ten
sit
y t
o n
orm
al)Imaging/
sacrifice
Macro-channel
Micro-channel
In
 v
iv
o
re
la
tiv
e 
m
R
N
A 
ex
pr
es
sio
n 
of
in
filt
ra
te
d 
ce
lls
 in
to
 h
yd
ro
ge
l
(co
mp
are
d t
o m
ac
ro-
ch
an
ne
l g
rou
p)
2.0
1.5
1.0
0.5
0.0
60 Macro-channel
Channel network gel
M1 macrophages
M2 macrophages
Micro-channel
Macro-channel
Micro-channel
Macro-channel
w/o channel
Micro-channel
R
el
at
iv
e 
m
R
N
A 
ex
pr
es
sio
n 
of
 R
AW
26
4.
7
in
 h
yd
ro
ge
l (c
om
pa
red
 to
 m
ac
ro-
ch
an
ne
l g
rou
p)
Ma
cro
-
ch
an
ne
l
Mi
cro
-
ch
an
ne
l
Mi
cro
-
ch
an
ne
l
Ma
cro
-
ch
an
ne
lw/o
ch
an
ne
l
50
40
30
20
10
120
R
at
io
 o
f M
1 
an
d 
M
2 100
80
60
40
20
0
0
M1
(iNOS)
M2
(CD206)
CD3 CD68 CD31
2.0
1.5
1.0
0.5
0.0
Cell seeding LPS Harvest
D02.0
1.5
14
12
10
8
6
4
2
0
1.0
0.5
0.0
IL-1β TNF-α
M1 polarization M2 polarization
CD80 NOS2 IL-10 Arg-1 CD163 CD206IL-6
D2
N.S.
N.S.
N.S.
D3
Sa
line
Ma
cro
-
ch
an
ne
l
Mi
cro
-
ch
an
ne
l
Hydrogel Hydrogel
Normal
hindlimb Saline
H
&E
CD
68
(m
ac
rop
ha
ge
)
CD68/DAPI
Micro-channel
cba
d e
f
g
Fig. 3 Monocyte/macrophage responses to test groups in a mouse model of hindlimb ischemia. a Gene expression (CD3, CD68, and CD31) of infiltrated
cells into macro- versus microchannel network hydrogels only after removing surrounding tissues at day 14 post-implantation by qRT-PCR (N= 3).
Data presented are mean ± SEM. Statistical significances are determined using a two-tailed Student’s t-test; *p < 0.05 between lined groups. b IVIS
images of monocyte infiltration into the implant site (hydrogel+ surrounding tissue) of each test group on day 1 post intravenous administration of
Vivotrack680-labeled RAW264.7 cells, followed by quantification of the ratio in ischemic to normal hindlimb (N= 3). Data presented are mean ± SEM.
Statistical significances are determined using one-way ANOVA with Tukey post-hoc pairwise comparisons; *p < 0.05 and ***p < 0.005 between lined
groups. c Representative H&E and immunostaining (CD68) images of ischemic hindlimb tissues at the implant site. Scale bar= 100 µm. d Confocal images
of macrophage polarization markers (M1: iNOS versus M2: CD206, both in green), a mouse macrophage marker (F4/80 in red), and nucleus (DAPI in
blue) at day 14 post-implantation. The corresponding M1 or M2 cell number % out of the total macrophage number (F4/80+) as well as M1/M2 ratios in
the macro- and microchannel groups were determined quantitatively. Scale bar= 100 µm. Data presented are mean ± SEM. Statistical significances are
determined using a two-tailed Student’s t-test; *p < 0.05 and ***p < 0.005 between lined groups (N= 4). e Gene expressions of M1 (IL-1β, IL-6, TNF-α,
CD80, and NOS2) and M2 (IL-10, arginase-1, CD-163, and CD-206)] markers in mouse macrophages (RAW264.7) post-culture within macro- versus
microchannel network hydrogels in vitro by qRT-PCR (N= 5). Data presented are mean ± SEM. Statistical significances are determined using a two-tailed
Student’s t-test; *p < 0.05 and ***p < 0.005 between lined groups (N.S.: not significant). Data presented are mean ± SEM. Quantification of endothelial cell
(human umbilical vein endothelial cell, HUVEC) f tubulogenesis and g migration induced conditioned media of RAW264.7 cells in vitro (N= 4). Dots
represent each replicate of HUVEC-seeded wells in a 24-well plate. Data presented are mean ± SEM. Statistical significances are determined using one-way
ANOVA with Tukey post-hoc pairwise comparisons; *p < 0.05 and ***p < 0.005 between lined groups. Source data are provided as a Source Data file.
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Wound healing model. To examine whether the microchannel
network hydrogel can be applied for another model of ischemic
damage where neighboring host vasculature is present, the test
groups were implanted in a well-established mouse model of
wound healing (Fig. 5). As demonstrated in the hindlimb ische-
mia model, neighboring vessels might grow into the hydrogel and
undergo a perfusion connection with the microchannel network.
Indeed, implantation of the microchannel group accelerated the
wound closure process in the wound area compared to the
macrochannel group and the w/o channel hydrogel group. This is
visualized (Fig. 5a and Supplementary Fig. 9) and quantitatively
analyzed (Fig. 5b) in our figures. This result was supported
by more robust tissue formation (H&E), richer collagen
content (Masson’s trichrome staining), and accelerated epidermis
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formation (keratinocyte staining) in the microchannel and nor-
mal tissue groups compared to the rest groups (no-treat, w/o
channel, and macrochannel) (Fig. 5c). Moreover, the micro-
channel group promoted infiltration of ECs and EPCs in the
wound area compared to the w/o channel group as shown by
their marker staining (CD31 and CD133, respectively). Interest-
ingly, the expression level of another EPC marker, CD34 was not
significantly different between the macro- and microchannel
groups (Fig. 5d), indicating potential, non-specific infiltration of
other CD34+ cell types such as bone marrow cells by both
channel groups. M2 polarization also increased in the micro-
channel group compared to the w/o channel group as presented
by the amount of section factors (IL10 and Arg1). CD 31
expression (EC marker) and IL10 secretion (M2 polarization)
were higher in the microchannel group compared to the mac-
rochannel group but the differences of other factor amounts
between the macro- and microchannel groups were not sig-
nificant, indicating relative difficulty to discern the channel size
effect in the wound healing model compared to the severe hin-
dlimb ischemia model.
Non-ischemic in vivo models. Given that both hindlimb ischemia
and wound closure models are exposed to insufficient oxygen
supply with a rich presence of neighboring host vessels, three other
in vivo models (implantation to the omentum, normal limb, and
subcutaneous tissue) were employed to determine the mechanistic
roles of the ischemia condition and neighboring blood vessels.
These three models are not subjected to ischemia, but the number
of neighboring vessels decreased from rich (omentum), to middle
(normal limb), and finally to poor (subcutaneous) levels. As
demonstrated in perfusion-based (red FluoroSpheres) confocal
images with CD31 staining (green) (Fig. 6a), (i) the microchannel
group showed the most effective perfusion from host vessels to the
implanted sample and the richest population of CD31+ cells; (ii)
however, these levels in the microchannel group decreased mark-
edly from the omentum model to the normal limb, and lastly, to
the subcutaneous model; and (iii) even though the perfusion per-
formance was most efficient in the microchannel group of the
omentum model among all non-ischemic test groups, its level
appeared to be lower than that of the microchannel group in the
hindlimb ischemia model. These results were supported by the
degrees of tissue ingrowth and blood cell infiltration in H&E
images (Fig. 6b) with a comparison focused only on the micro-
channel groups (Fig. 6c) and CD31+ cell infiltration (Fig. 6d). In
the three models, the w/o channel and macrochannel groups
showed only a few or no CD31+ cells (Supplementary Fig. 10). The
results indicate mechanistic roles of the ischemic condition and
neighboring blood vessels in guiding the microchannel effect.
Furthermore, the assistance to channel size effect was compared for
the ischemic versus normal condition using the marker gene
expression of infiltrated cells in the implanted hydrogels on day 14
post-implantation (Fig. 6e). The ischemic condition assisted the
microchannel effect most effectively on vessel infiltration (CD31,
KDR, vWF, and αSMA), whereas there was no noticeable effect of
channel size and ischemic condition on infiltration of skeletal
muscle (MyoG) and EPC (CD34 and CD133). Interestingly,
regardless of the channel size, the ischemic condition promoted
increased infiltration of monocyte/macrophage (CD68) and T cells
(CD3) into the implanted hydrogels when compared to the normal
side.
Discussion
This study developed an implantable hydrogel with a perfusable
microchannel network to treat ischemic/inflammatory disease by
promoting angiogenesis and M2 polarization of the infiltrated
monocytes/macrophages. We believe that this study significantly
contributes to the field of regenerative medicine, in particular to
the biotechnology areas where significant efforts have been made
over the past decades to vascularize damaged tissues or implan-
table scaffolds. The study is based on the idea that a pre-
engineered 3D microchannel network enabled vascular perfusion
throughout the hydrogel implant via the ingrowth of neighboring
host vessels and a perfusion connection with microchannels.
Notably, this regenerative function was programmed by only the
microchannel structure without loading any cells or therapeutic
molecules. The microchannel size (16.37 ± 7.76 µm) and closed
3D network played a crucial role in guiding this regenerative
mechanism in the gelatin hydrogel implantation14,15. The
microchannel size was set up first to mimic the diameter range of
capillary (5–10 µm), a small blood vessel38. Second, our previous
studies proved that this diameter range of pores promoted micro
blood vessel formation into the polymer’s scaffolds when
implanted subcutaneously in mice39 while also accelerating the
histological and functional recoveries of post hepatectomy liver
via implantation of the same vascular network hydrogel that also
contained minced pieces of autologous liver tissue in rabbits31.
Lastly, a study reported that ~15 µm diameter pores induced M2
polarization and angiogenic activities40. The microchannel gel
enabled perfusion from the upper stream to the implanted gel and
beyond, even to the lower extremity (Fig. 1c), which served as an
indirect indication of longitudinal blood flow. While this inter-
pretation is macroscopic, the ingrowth and perfusion connection
of host vessels were not only longitudinal but also of random
direction as shown by microCT and fluorescent bead imaging
(Fig. 2). Since the main outlet point of the microchannel is
downstream of ligated femoral vessels, it is assumed that random
directional microflow likely passed through the implanted
hydrogel and collectively flew into the downstream outlet point
through the perfusion connection, resulting in the longitudinal
Fig. 4 In vivo infiltration and ingrowth of ECs within channel network hydrogels. EC infiltration and ingrowth within channel network hydrogels from 2-
week implantation in mouse (a–f) and porcine (h) models of hindlimb ischemia. a Gene expression of infiltrated cells between macro- and microchannel
groups at day 14 post-implantation (N= 3). Dots represent each replicate. Data presented in mean ± SEM. Statistical significances are determined using
two-tailed Student’s t-test; *p < 0.05 between lined groups (N.S.: not significant). b H&E images of implanted channel network hydrogels. In the box with
high magnification (right, i), yellow arrows indicate sites where blood cells infiltrated the microchannel network hydrogel. Scale bar= 100 µm. c Confocal
images of functional ECs (lectin+), in macro- and microchannel groups and d quantitative analysis of lectin+ channel size distribution. The images were
obtained from whole-mount hydrogels post-EC staining (green, lectin) and channel perfusion (red, microbeads). Scale bar= 100 µm.White arrows indicate
co-localization of functional ECs (green) and perfusion-stained channel (red). e Confocal images of whole-mount hydrogel with macro- or microchannel
network post co-immunostaining of CD31 (green), F-actin (red), and nucleus (blue). Scale bar= 100 µm. f Confocal images of whole-mount hydrogel with
macro- or microchannel network post co-immunostaining of CD34/CD133 (red) and F-actin (green) with nucleus (blue). Scale bar= 100 µm. g Confocal
image of ECs (GFP-HUVEC) lining a microchannel network in vitro (i: a cross-sectionaview of EC-lined channel). Scale bar= 100 µm. h H&E images of
implanted channel network hydrogels in porcine hindlimb ischemia. Yellow arrows indicate the sites where blood cells infiltrated in the microchannel group.
Scale bars= 5mm for digital images and 100 µm for H&E images. Source data are provided as a Source Data file.
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flow direction observed under the macroscopic doppler imaging
(Fig. 1c).
The idea to generate a 3D-interconnected structure of sacrifi-
cial fibers originated from the cotton candy machine, because
electrospinning did not work in depositing the volumetric fiber
mesh, and 3D printing was not able to reach sufficient resolution
for producing the closed network of dense fibers41,42. Only a
cotton candy machine-like production of sacrificial fibers enabled
nutrient diffusion limits to be overcome, which was a game-
changer in this approach43,44. The use of enzyme cross-linkable
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gelatin hydrogel added practical value because it is cheap, bio-
compatible, and enables easy loading of cells and therapeutics
before gelation. Moreover, its cross-linking time and degree are
highly controllable by adjusting the enzyme to gelatin ratio,
facilitating application to a wide range of tissues and organs45,46.
Since microbial transglutaminase (mTG) cross-links glutamine
and lysine via a transamidation reaction, the mechanical prop-
erties of the gelatin hydrogel depended on the mTG dosage and
the amounts of these molecules as presented by the gelatin con-
centration. Previous studies reported that the gelation time of
mTG gel ranged from ~15 s to hours with a constant mTG
concentration (10 U g−1)47–49.
The microchannel hydrogel induced invasion and M2 polar-
ization of monocytes (Fig. 3) and thereby promoted EC ingrowth
from the host vessel side (Fig. 2) to localize into microchannels
(Fig. 4), leading to the facilitation of blood perfusion (Fig. 1).
Based on comparisons with the other test groups, the micro-
channel size was determined to play a key role in exerting this
beneficial effect for the following reasons: (i) the saline control
group showed a negligible effect on blood perfusion and limb
rescue during 2-week implantation in the mouse hindlimb
ischemia model (Fig. 1c). (ii) As an indication of the gelatin
formulation effect, the gelatin hydrogel without channels (w/o
channel group) demonstrated similar levels of negligible regen-
erative and pro-angiogenic effects (Figs. 1 and 2) to those of saline
control group (Fig. 1c–e). (iii) When the same gelatin formation
was kept, the reduction of channel size from the macrochannel
group to the microchannel group resulted in remarkable pro-
motion of beneficial effects throughout the study.
In this study, the microchannel function required hypoxic
conditions and neighboring host vessels as a catalyst and a sup-
porting reactor, respectively (Fig. 6). The evidence indicates that
angiogenesis from host vessels made bridging of blood perfusion
with microchannels and provided cellular and matrix sources for
tissue regeneration. Promising results were demonstrated using a
large porcine model, although the large size of the porcine vessels
hampered the clear visualization of blood perfusion through the
implantation site using current imaging tools. An inevitable issue
in the use of pigs was their potent ability to induce spontaneous
collateral formation and regenerate damaged tissues, even with-
out any aid. This spontaneous vessel formation attenuated the
response variation between ligated and unligated hindlimbs.
Hence, a baboon or a dog model may be more suitable for future
investigation. On the other hand, it can be assumed that
the hydrogel porosity and degradability might be altered during
the implantation period, as these are strongly interrelated, and
may have thereby affected the results. When the porosity changes
and degradability of hydrogels were determined in mice (post 2-
week subcutaneous implantation) (Supplementary Fig. 11a, b),
neither the porosity nor the degradability was significantly
different between the macro- and microchannel groups.
The degradability percentages of the channel groups were not
significantly different from that of the w/o channel group
(Supplementary Fig. 11b), indicating no significant effect of the
porosity and degradability on the entire in vivo results. Also,
regardless of channel size, the average pore sizes of macro- and
microchannel groups increased to similar degrees after 2-week
accelerated degradation in vitro. As a result, the difference of
channel size between the macro- and microchannel group
remained unaltered even after 2-week degradation, indicating
non-significant effects of degradation and consequent pore size
changes on the results (Supplementary Fig. 11c).
The transition from bench to clinical application requires an easy
and fast fabrication process with scalable production. The produc-
tion process of the microchannel network hydrogel needs only three
simple steps (i.e., sacrificial fiber generation, hydrogel gelation with
the fiber mesh embedding and removal). Moreover, as demon-
strated in the large porcine model (Fig. 4h) and mouse wide-wound
model (Fig. 5), the dimension of the channel hydrogel is scalable by
changing the PDMS mold size and increasing the amounts of
sacrificial fibers and gelatin hydrogel. With its inexpensive and easy
production process, the regenerative effect of this microchannel
network hydrogel is highly promising and applicable to peripheral
artery disease (PAD) treatment. Considerable progress has been
made in surgical and non-surgical treatments for patients with
PAD, and there is still an unmet need to restore blood flow to
ischemic tissues while avoiding detrimental inflammation and other
side effects. Most strategies overlook the mechanistic role of the
destructive inflammatory activation in PAD progression50–52. For
this reason, the proposed approach can serve as an innovative
platform for PAD treatment, as the microchannel network can
induce pro-regenerative and pro-angiogenic monocyte polarization.
Therefore, there is clear value in its transition toward clinical
applications. The next version of the system will be designed to
accelerate the perfusion connection to host vessels to enhance the
clinical feasibility of the hydrogel. As one idea in a current trial, a
central macrochannel line is formed in connection with surround-
ing microchannels so that the macrochannel can be surgically
connected with host vessels post cannulation following the method
discussed in a previous study53. In this case, the gel stiffness would
be also adjusted to withstand the physiological pressure, and an
anti-coagulant would be used to prevent thrombotic occlusions in
the microchannel as demonstrated in our other recent study54.
Although the current study is entirely focused on elaboration of the
channel size as a key factor to enable ischemic blood perfusion
connection, similar results may be obtained if the hydrogel is fab-
ricated with same channel size using other materials. Therefore, this
topic will be examined in the next step of study.
Methods
Device fabrication. As a sacrificial material to generate channel networks, PNI-
PAM (Mn= ~40,000, Sigma–Aldrich, St. Louis, MO), was dissolved in methanol at
a concentration of 45% (weight volume−1). The fiber diameter was controlled by
changing the spinning RPM in custom-built rotational spinning device31,44. The
macro- and microfiber sizes were produced by spinning 45% PNIPAM/MeOH
solution at 1000–1500 and 2500–2800 rpm, respectively. Next, PNIPAM fibers at a
density of 11.45 ± 3.13 μg mm−3 were placed in the PDMS mold, and a silicone
Fig. 5 Regenerative effects of test hydrogels on wound closure. a Schematic illustration of hydrogel implantation into a wound site post-full-thickness
defect of mouse dorsal skin with the discovered regeneration process (top box). Photographs of wound healing sites at day 14 post-implantation (bottom
row). Scale bar= 1 cm. b Degrees of decreased wound area from the initial 2 × 2 cm defect in each group at day 14 post-implantation (N= 4). Dots
represent each animal. Data are presented as mean ± SEM. Statistical significances are determined using one-way ANOVA with Tukey post-hoc pairwise
comparisons; *p < 0.05 and ***p < 0.005 between lined groups. c Representative images of general histology (H&E), collagen formation (Masson’s
trichrome), keratinocyte-epidermis lining (green Involucrin), and CD31+ cells (green) with nuclei (blue DAPI). White arrows point out microvascular
structures (CD31+) in the skin tissue sections. Scale bar= 100 µm. d Marker gene expression of EC (CD31), EPC (CD34 and CD133), and M2 polarization
(IL10 and Arg1) in the wound area of mouse dorsal skin at day 14 post-implantation by qRT-PCR (N= 3). Dots represent each animal. Data are presented
as mean ± SEM. Statistical significances are determined using one-way ANOVA with Tukey post-hoc pairwise comparisons; *p < 0.05 between lined
groups (N.S.: not significant). Source data are provided as a Source Data file.
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tube was placed to connect with the fibers at the inlet and outlet sides so that flow
could be perfused through the inlet silicone tube to the fiber-generated channel
network and to the outlet silicone tube. Then, a gelatin/mTG solution (9:1 ratio,
final concentration= 5% weight volume−1) was poured onto it, followed by a
cross-linking reaction with mTG at 37 °C. The embedded fibers were dissolved
away from the mTG hydrogel by sol–gel transition of PNIPAM at room tem-
perature with perfusing PBS in connection with the silicone tube (Supplementary
Figs. 1a and 3). As a result, a 3D micro- or macrochannel network was formed in
the gelatin hydrogel. The channel networks were visualized by perfusing red
FluoroSpheres (45 nm, Invitrogen) and then imaged by confocal microscopy (LSM
780, Zeiss). The channel size distribution of the macro- and microchannels in the
hydrogel was quantified using ImageJ/Fiji software. The channel network of test
gelatin hydrogel was perfused with culture media containing FITC-dextran
(molecular weight= 40,000, Sigma-Aldrich, MO) and red FluoroSpheres (45 nm,
Invitrogen) throughout the channel network of test hydrogel at 20 μmmin−1 for
30 min, followed by confocal imaging (LSM 780, Zeiss) to determine its diffusivity
and perfusability, respectively.
Mouse and porcine models of hindlimb ischemia. All procedures of mouse and
porcine studies were approved by the Institutional Animal Care and Use Com-
mittee (IACUC) of Yonsei University College of Medicine (2016-0194 and 2017-
0058 for mouse and porcine, respectively). For the mouse model, 5-week-old Balb/c
male mice (Orient bio., Republic of Korea) with a weight range of 20–25 g were
subject to anesthesia by intraperitoneal injection of xylazine (10 mg kg−1) and
zoletil (50 mg kg−1). In their left limbs, the upper and lower points of femoral
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artery and vein were ligated using a 6-0 silk suture (Ethicon, Somerville, NJ)32
(Supplementary Fig. 5a), followed by resection of vessels between the two points.
The ligation points were the proximal branch point of the external iliac artery and
the distal point where it bifurcates into the saphenous and popliteal arteries. A test
group hydrogel (4 mm × 4mm× 3mm) was implanted into the center hindlimb
muscle of the ischemic vessel-resected area in a post-surgery mouse (Figs. 1–4) or
the same muscle position of the non-ischemic hindlimb in a normal mouse (Fig. 6)
to comparatively determine the ischemic effect until euthanized in 14 days. As
another ischemia model in mice, a full thickness defect was induced on the dorsal
skin of a mouse (Fig. 5). Then, a test group hydrogel (2 cm × 2 cm × 3 mm) was
placed to cover the defect site by sealing with dressing film (TegadermTM, 3M
Medical) for 14 days. As non-ischemic models, greater omentum and subcutaneous
tissue with 14-day hydrogel implantation served as host neighboring vessel-rich
and vessel-poor models, respectively, to determine the mechanistic role of the
number of host vessels in angiogenesis-mediated perfusion connection with
channel networks. Four mice were grouped to each wire-mesh cage ((W) 200 × (D)
260 × (H) 130 mm) and housed in a temperature (22 ± 2 °C) and humidity (50 ±
10%) regulated environment with a 12-h light–dark cycle.
For a porcine model of hindlimb ischemia, 3-month-old female Yorkshire pigs
(XP Bio, Republic of Korea) of 40 kg were subject to intramuscular injection of
atropine (0.04 mg kg−1), xylazine (2 mg kg−1), and azaperone (2 mg kg−1) as
premedication. Anesthesia was then induced with Alfaxan (1 mg kg−1) and was
maintained by endotracheal intubation of 2% isoflurane during surgery. As with
the mouse model of hindlimb ischemia, the femoral artery and veins were ligated
with 1-0 silk and dissected. Test group hydrogels (cylinder shape: 1 cm in diameter
and 1.5 cm in height) were implanted into the central hindlimb muscle of the
ischemic area until euthanized in 18 days for histological examination (H&E).
Because discrimination between the inside and outside of the hydrogel is only
possible using histology, histological analysis was conducted on the hydrogel
together with connected tissues immediately after harvesting. The hydrogel part
was carefully dissociated from the connected tissue part, and the two parts were
used separately to conduct quantitative PCR because positional discrimination was
not possible using quantitative PCR (Supplementary Table 1).
In vivo and in vitro degradability and porosity measurement. The in vivo
degradability of the gelatin hydrogel groups (i.e., w/o channel, macrochannel, and
microchannel in 1 cm diameter with 2 mm thickness) was determined by sub-
cutaneously implanting into mice for 2 weeks (N= 4). Each test sample was then
harvested, rinsed with PBS three times, and lyophilized to measure its dry weight.
The mass loss as an indication of degradation degree was calculated by comparing
to the corresponding dry weight before implantation (%). At the same time, the
porosity of macro- or microchannel hydrogels was determined by calculating the
relative dry weight to that of w/o channel hydrogel (%) post 2-week subcutaneous
implantation in mice. Sample degradation was accelerated in vitro by immersing in
PBS with stirring at 37 °C for 2 weeks. Samples were freeze-dried for 24 h and
horizontally sectioned. The pore sizes of test groups were observed by field emis-
sion scanning electron microscopy (FE-SEM; MERLIN, Zeiss, Oberkochen, Baden-
Württemberg, Germany), followed by quantitative analysis of the pore size using
ImageJ/Fiji software.
Laser Doppler imaging. Blood perfusion into the implant areas was determined at
days 0, 7, and 14 post surgery by LDPI (Moor Instruments, Devon, UK) with
quantitative analysis of LDPI values. The mouse body temperature was maintained
by keeping it on a heating pad during LDPI scanning to minimize perfusion
variations. The highest and lowest values of perfusion (LDPI) were color-coded to
red and dark blue, respectively. The relative perfusion ratio was calculated by
dividing the mean perfusion value of the ischemic hindlimb (left) by that of the
normal hindlimb (right) from the corresponding LDPI image. Degrees of limb loss
were determined following the reported amputation criteria in previous
studies55,56. Tissue damage in the ischemic limb (limb salvage score) was graded as
full recovery (grade 6), minor necrosis or nail loss (grade 5), partial toe amputation
(grade 4), total toe amputation (grade 3), partial/total foot amputation (grade 2), or
partial/total limb amputation (grade 1). Following these criteria, the damage degree
of ischemic hindlimb tissue was quantitatively determined and presented as a limb
salvage % among the ranges of limb rescue (recovery), toe loss, foot loss, and limb
loss (amputation). Although the biological N (animal number) was 5, the degree of
hindlimb ischemia salvage was scored by three blinded evaluators, and thus, the
technical N was 11–14.
MicroCT angiography. Blood perfusion from host blood vessels to each implanted
hydrogel was determined by microCT angiography. After anesthetizing with iso-
flurane, the mice were subject to a tail vein injection of Pamiray 370 (100 µL of
iopamidol-370, Dongkook CO., LTD, Republic of Korea) as a contrast agent and
then to microCT scanning (NFR Polaris-G90, Nano Focus Ray, Korea) following a
standard protocol (tube voltage: 65 Kvp; tube current: 115 µA; 720 views per 360°
rotation; resolution: 100 μm). The acquired microCT images were reconstructed
using the volumetric cone-beam reconstruction (FDK) algorithm, and analyzed
using a 3D-rendering software (RadiAnt DICOM Viewer 4.2.1).
In vivo EC infiltration and host vessel ingrowth. EC infiltration from the
distal site of the ischemic hindlimb to the implanted hydrogels was determined
by confocal imaging post tail vein injection of lectin (100 μL, FITC-conjugated,
L-2895, Sigma–Aldrich) for 30 min. Flow perfusion connection from neighboring
vessels to channel networks was imaged according to a previously reported
method57,58. Briefly, after cutting the inferior vena cava of the mouse, PBS con-
taining 0.1 mg mL−1 heparin sulfate was perfused through the left ventricle to
remove whole blood through the cut drain point. PBS containing red fluorescent
microbeads (45 nm in diameter, Invitrogen) was then perfused through the left
ventricle for fluorescence visualization of perfusable vessels and channels, followed
by sample harvest and fixation with 3.7% formaldehyde. Z-stacks of each whole-
mount sample (gel with neighboring tissue) was subject to confocal imaging (LSM
780, Zeiss), followed by quantitative analysis of functional vasculature parameters
(i.e. total branching length, branch number, junction number, and blood vessel
fractional area per field of view) using ImageJ/Fiji software.
Tissue and cell staining. The harvested samples were rinsed with PBS three times
and then fixed with 10% weight volume−1 paraformaldehyde for 1 day, followed by
embedding in paraffin to make sections. Sections of 4 µm thickness were obtained
from six different locations of each block by microtome slicing, then subjected to
staining with H&E and Masson’s trichrome for analysis of general histology and
tissue fibrosis, respectively, by inverted microscopy (Leica DMi8, Leica Micro-
systems, Wetzlar, Germany).
The same sections were reused for immunofluorescence staining, and thus,
hydrated by serial incubation in xylene and ethanol (100%, 95%, 80%, and 70%
volume volume−1 in distilled water), followed by treatment with pepsin reagent
(Sigma–Aldrich) for 30 min at 37 °C to retrieve antigens. The whole-mount sample
was subject to blocking with a buffer solution of 5% weight volume−1 bovine serum
albumin (Millipore) and 0.3% (weight volume−1) Triton X-100 (Sigma–Aldrich)
for 1 h at room temperature. The sample blocks were then incubated with primary
antibodies (1:100 dilution) for CD68 (ab125212, Abcam), CD31 (sc-1505, Santa
Cruz Biotechnology), Involucrin (sc-21748, Santa Cruz), F4/80 (ab6640, Abcam),
iNOS (ab955, Abcam), and CD206 (ab64693, Abcam) overnight at 4 °C, followed
by incubation with Alexa Fluor 488 or Alexa Fluor 594-conjugated secondary
antibodies (1:100 dilution) (Jackson Immuno Research Laboratories, West Grove,
PA, USA). The sample blocks were counterstained with DAPI (H-1500, Vector
Fig. 6 Vascularization efficiencies of microchannel hydrogel implantation in non-ischemic mouse models. The number of surrounding host vessels
decreases from the greater omentum to normal hindlimb, and lastly, to the subcutaneous site. a Confocal images of whole-mount hydrogels post perfusion
of blood vessels (red fluorescence microbeads) with immunostaining of CD31+ cells (green) and nucleus (blue DAPI) at day 14 post-implantation. The
images were three-dimensionally reconstructed to determine vascular ingrowth and perfusion connection through red FluoroSphere perfusion from host
vessels into the channel network. Scale bar= 100 µm. b Representative H&E images of test groups. The box areas (100×) were magnified to c (200×).
Scale bar= 100 µm. c High magnification (200×) H&E images from black-dotted boxes of micro-channel group in b. Blue arrows indicate the points where
blood cells infiltrated into the implanted hydrogel or surrounding tissue of the greater omentum, normal hindlimb, and subcutaneous site (no blood cell
infiltration). Scale bar= 100 µm. d Confocal images of CD31+ cells (green) in the sectioned tissues of each model containing a part of microchannel
network hydrogel (blue: nucleus with DAPI staining). Scale bar= 100 µm. e Effects of channel size on cell infiltration into the normal side versus the
ischemic hindlimb side, as presented by marker gene expression of the vessel (CD31, KDR, vWF, and αSMA), skeletal muscle (MyoG), monocyte/
macrophage (CD68), T cell (CD3), and EPC (CD34 and CD133) cells in macro- and microchannel network hydrogels. qRT-PCR was conducted using only
gel samples after removing the surrounding tissues on day 14 post-implantation (N= 4). Dots represent hydrogel sample in each animal. Data are
presented mean ± SEM. Statistical significances are determined using two-tailed Student’s t-test; *p < 0.05, **p < 0.01, and ***p < 0.005 between lined
groups (N.S.: not significant). Source data are provided as a Source Data file.
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Laboratories) and imaged by confocal microscopy (LSM 780, Zeiss) with
quantitative analysis using ImageJ/Fiji software.
Cell apoptosis in samples was determined by TUNEL staining (Roche
Molecular Biochemicals, Mannheim, Germany) according to the manufacturer’s
protocol, followed by confocal imaging (LSM 780, Zeiss) with quantitative analysis
using the ImageJ/Fiji software.
For whole-mount staining of the hydrogel, hydrogel samples were rinsed with
PBS three times and then fixed with 10% paraformaldehyde for 1 day. The hydrogel
samples were rinsed with PBS again and treated with primary antibodies (1:100
dilution) for CD31 (sc-1505, Santa Cruz Biotechnology, Dallas, Texas), CD34
(ab81289, Abcam, Cambridge, MA), CD133 (ab19898, Abcam) overnight at 4 °C,
followed by treatment with Alexa Fluor 488 or Alexa Fluor 594-conjugated
secondary antibodies (1:100 dilution; Jackson Immuno Research Laboratories,
West Grove, PA). Cell nuclei were counterstained with DAPI (4′,6-diamidino-2-
phenylindole; H-1500, Vector Laboratories) and imaged via confocal microscopy
(LSM 780, Zeiss).
Macrophage infiltration and polarization. In vivo monocyte infiltration to
implantation sites was determined by labeling mouse monocytes (RAW264.7) with
a fluorescent dye (Vivotrack 680, PerkinElmer, MA) according to the manu-
facturer’s instruction. These monocytes (2 × 106 cells per mouse) were injected
intravenously at day 3 post hindlimb ischemia surgery (n= 4), and their bio-
distribution was determined using an IVIS (PerkinElmer) at 24 h post injection.
The Vivotrack intensity at the gel implantation site of ischemic hindlimb was
analyzed in comparison with that of the normal hindlimb. Samples were harvested
post mouse euthanasia and processed for other studies.
In vitro macrophage polarization was determined by culturing RAW264.7 cells
(5 × 105 cells) in channel hydrogels with media perfusion at 20 μLmin−1 by
peristaltic pumping for 2 days. The samples were treated with LPS (100 ng mL−1)
to induce inflammatory activation of RAW264.7 cells for 1 day and then subject to
qRT-PCR analysis.
The effect of channel size on monocyte/macrophage polarization was
confirmed by determining the migration and tubulogenesis of ECs under
treatment of conditioned media. The conditioned media was obtained from a 2-
day culture of RAW264.7 cells (5 × 105 cells) within each hydrogel with a media
perfusion at 20 μL min−1 via peristaltic pumping. As a control condition for M1
polarization, RAW264.7 cells were cultured under treatment of LPS (100 ng mL
−1). For the tubulogenesis assay, human umbilical vein ECs (HUVECs, 2 × 105
cells per well) were seeded onto matrigel (Corning, NY) in 24-well plates
(ThermoFisher Scientific). For the migration assay, a PDMS disc (Dia.= 2 mm
and thickness= 4 mm) was placed onto each of 24 wells, and the same number of
HUVECs were seeded into the well such that HUVECs could migrate into the
blank area where the PDMS disc was removed. Endothelial growth media (EGM-
2, Lonza, Basel, Switzerland) was treated for 2 h to allow HUVEC attachment,
followed by replacement of the media with the conditioned media from each test
group. Tubulogenesis of HUVECs was imaged at 8 h post treatment of the
conditioned media and analyzed using an angiogenesis analyzer plug-in at
ImageJ/Fiji software. For the migration assay, PDMS disc was removed
immediately after treatment of the conditioned media, and HUVEC migration
into the blank area was then imaged at 8, 16, and 24 h post treatment of the
conditioned media, so that the HUVECs’ covering area could be quantitatively
determined.
Quantitative RT-PCR analysis. Total RNA was prepared from implanted samples
using TRIzol® reagent and was then treated with DNase, followed by reverse
transcription with RNA (1 μg) and random-hexamer primers to generate cDNA
using a kit (TAKARA Bio Inc., Japan). Quantitative PCR was conducted with
cDNA using SYBR® Green and primers (forward and reverse) in a StepOneTM
Real-Time PCR system (Applied Biosystems, Foster City, CA). The relative gene
expression level was determined by calculating the corresponding comparative Ct
(2−ΔΔCt) value against that of glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) as a housekeeping gene. The primer sequences are listed in Supple-
mentary Table 1.
Statistical analysis. Each experiment was repeated three times. All data are pre-
sented as a mean ± SEM. All quantitative data were analyzed using a two-tailed
Student’s t-test or one-way analysis of variance (ANOVA) with Tukey’s significant
difference post-hoc test for multiple comparisons (SPSS 21.0K for Windows, SPSS,
Chicago, IL, USA). Values of *p < 0.05, **p < 0.01, and ***p < 0.005 were considered
statistically significant.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1b, d, e, g, and h, 2d–g, 3a, b, and d–g, 4a, 5b and d, 6e,
and Supplementary Fig. 11a–c are provided as a Source Data file. All other relevant data
are available upon request.
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